Bailey Perrin Bailey - A Registered Limited Liability Partnership - 1-866-716-8300

Digitek

On April 25, 2008, Actavis Totowa LLC announced a Class I nationwide recall for the heart drug Digitek (digoxin), which the company manufacturers for Mylan Pharmaceuticals Inc. and UDL Laboratories. The recall was announced after the FDA found that Digitek tablets appeared to be double the thickness of typical tablets, and became concerned that these tablets contained twice the active ingredient.

Digitek (digoxin) is a prescription drug used to treat heart failure and arrhythmia. If patients take twice the prescribed dosage of this medication, it can lead to “digoxin overdose” which can cause serious injuries and even death. Symptoms of digoxin overdose may include any of the following: nausea, vomiting, decreased appetite, diarrhea, confusion, seizures, hallucinations, light "halos" around objects, green or yellow vision, fatigue, irregular heartbeats, and abnormally fast or slow heartbeats.

Bailey Perrin Bailey is aggressively representing patients who may have been injured by recalled Digitek tablets. To request a free, no obligation, legal consultation, please submit the inquiry form on this page, or call 1-866-716-8300.

Asbestos Exposure Digitek / Digoxin Recall

Firm News

3 Schizophrenia Drugs May Raise Diabetes Risk

Read more »

Digitek Recall Blamed on Shoddy Manufacturing

Read more »

Arkansas AG sues Big Pharma

Read more »

Paxil Maker Agrees to Reimburse Insurance Companies $40 Million

Read more »

© 2008 Bailey Perrin Bailey. Disclaimer: All states and jurisdictions have statutes that make it unlawful for any person or group of persons to hold themselves out as attorneys unless admitted and licensed to practice as attorneys at law. Bailey Perrin Bailey LLP attorneys practice only in jurisdictions or courts where they are admitted. In some jurisdictions this site may be considered advertising. Advertising disclaimers are required in several states when law firms or attorneys indicate practice limitations or areas of concentration.